DADE(R) CK-MB/MYOGLOBIN IMMUN CONTROL, I,II,III— 510(k) K926046

Substantially Equivalent

Baxter Diagnostics, Inc.

FDA 510(k) clearance K926046 for DADE(R) CK-MB/MYOGLOBIN IMMUN CONTROL, I,II,III, Substantially Equivalent on 1993-01-05. Applicant: Baxter Diagnostics, Inc..

Clearance details

Applicant: Baxter Diagnostics, Inc.
Product code: Code JJY
Advisory panel: Clinical Chemistry
Date received: 1992-12-01
Decision date: 1993-01-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.